Skip to main content

Multifocal Motor Neuropathy (MMN)

A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
NCT00701662 | PHASE 2 | INTERVENTIONAL

The objective of this study is to assess efficacy, safety, and convenience of purified human antibodies administered under the skin in the treatment of MMN patients.

Trial Information
3 Sites
8 Participants
Recruiting
18 Years to 17 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

San Raffaele Hospital
Milan,Italy
Inselspital
Bern,Switzerland
Dept. Clinical Immunology, Oxford Radcliffe Hospitals
Oxford,United Kingdom

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov